Free Yourself From Contacts and Glasses

The EVO Visian ICL procedure can help you live life uninhibited by getting rid of the hassles of contacts and glasses.

See Life in Full Detail

Explore the EVO Visian Implantable Collamer® Lenses to unlock visual freedom and a life rich with new experiences.
About the EVO Lens
Bye Bye Dry Eye

Bye Bye, Dry Eye

Unlike other vision correction procedures, EVO does not cause dry eye syndrome, which could mean a more comfortable journey as you achieve visual freedom.

Envision a Life Without Hesitation

Envision a Life
Without Hesitation

From hitting the gym to hitting the waves, EVO means you’re always ready to live life to the fullest.

Experience the More Natural Choice

Experience the More Natural Choice

EVO is vision correction that’s in harmony with your natural eye, keeping it completely intact.

Home Day Image Home Night Image

See Clearly Day and Night

Whether on an adventure or simply reading about one, EVO helps you see clearly – day and night.

Your Futures Bright

Your Future’s Bright,
And Protected

EVO has a unique barrier of UV protection.

Ready to Discover Visual Freedom With EVO? Find a Doctor Today

Important Safety Information

The EVO/EVO+ ICLs are designed for the correction/reduction of myopia in adults ranging from -0.5 D to -20.0 D with less than or equal to 6.0 D of astigmatism at the spectacle plane. The Canada EVO models have a spherical power range of -3.0 D to -18.0 D and cylinder power range of 1.0 D to 6.0 D. The Canada EVO+ models have a spherical power range of -3.0 D to -14.0 D and cylinder power range of 1.0 D to 6.0 D. The hyperopic ICL’s are available in powers ranging from +3.0 to +10.0 diopters for the correction/reduction of hyperopia. The ICLs are indicated for patients who are 21 to 60 years of age. In order to be sure that your surgeon will use a ICL with the most adequate power for your eye, your nearsightedness, farsightedness and astigmatism should be stable for at least a year before undergoing eye surgery. ICL surgery may improve your vision without eyeglasses or contact lenses. ICL surgery does not eliminate the need for reading glasses, even if you have never worn them before. ICL represents an alternative to other refractive surgeries including, laser assisted in situ keratomileusis (LASIK), photorefractive keratectomy (PRK), incisional surgeries, or other means to correct your vision such as contact lenses and eye glasses. Implantation of an ICL is a surgical procedure, and as such, carries potentially serious risks. The following represent potential complications/adverse reactions reported in conjunction with refractive surgery in general: additional surgeries, cataract formation, loss of best corrected vision, raised pressure inside the eye, loss of cells on the innermost surface of the cornea, conjunctival irritation, acute corneal swelling, persistent corneal swelling, endophthalmitis (total eye infection), significant glare and/or halos around lights, hyphaema (blood in the eye), hypopyon (pus in the eye), eye infection, ICL dislocation, macular oedema, non-reactive pupil, pupillary block glaucoma, severe inflammation of the eye, iritis, uveitis, vitreous loss and corneal transplant. Before considering ICL surgery you should have a complete eye examination and talk with your eye care professional about ICL surgery, especially the potential benefits, risks, and complications. You should discuss the time needed for healing after surgery.

References

References

1. Patient Survey, STAAR Surgical ICL Data Registry, 2018

2. Sanders D. Vukich JA. Comparison of implantable collamer lens (ICL) and laser-assisted in situ keratomileusis (LASIK) for Low Myopia. Cornea. 2006 Dec; 25(10):1139-46. Patient Survey, STAAR Surgical ICL Data Registry, 2018

3. Naves, J.S. Carracedo, G. Cacho-Babillo, I. Diadenosine Nucleotid Measurements as Dry-Eye Score in Patients After LASIK and ICL Surgery. Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2012.

4. Shoja, MR. Besharati, MR. Dry eye after LASIK for myopia: Incidence and risk factors. European Journal of Ophthalmology. 2007; 17(1): pp. 1-6.

5a. Lee, Jae Bum et al. Comparison of tear secretion and tear film instability after photorefractive keratectomy and laser in situ keratomileusis. Journal of Cataract & Refractive Surgery , Volume 26 , Issue 9 , 1326 - 1331.

5b. Parkhurst, G. Psolka, M. Kezirian, G. Phakic intraocular lens implantantion in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481.

*American Refractive Surgery Council